beta-lapachone, a novel topoisomerase I inhibitor, has significant cytotoxicity against multiple myeloma (MM) cell lines and patient cells.

Gupta, D, Tai, YT, Podar, K, Lin, BK, Akiyama, M, LeBlanc, R, Catley, LP, Mitsiades, C, Chauhan, D, Mitsiades, N, Hideshima, T, Schlossman, RL, Richardson, PG and Anderson, KC (2001). beta-lapachone, a novel topoisomerase I inhibitor, has significant cytotoxicity against multiple myeloma (MM) cell lines and patient cells.. In: Blood. , , (376A-376A). .

Author Gupta, D
Tai, YT
Podar, K
Lin, BK
Akiyama, M
LeBlanc, R
Catley, LP
Mitsiades, C
Chauhan, D
Mitsiades, N
Hideshima, T
Schlossman, RL
Richardson, PG
Anderson, KC
Title of paper beta-lapachone, a novel topoisomerase I inhibitor, has significant cytotoxicity against multiple myeloma (MM) cell lines and patient cells.
Proceedings title Blood   Check publisher's open access policy
Journal name Blood   Check publisher's open access policy
Publication Year 2001
Sub-type Published abstract
ISSN 0006-4971
Volume 98
Issue 11
Start page 376A
End page 376A
Total pages 1
Language eng
Q-Index Code EX
Q-Index Status Provisional Code
Institutional Status Unknown

Document type: Conference Paper
Collection: ResearcherID Downloads
 
Versions
Version Filter Type
Citation counts: TR Web of Science Citation Count  Cited 1 times in Thomson Reuters Web of Science Article | Citations
Google Scholar Search Google Scholar
Created: Sat, 20 Jul 2013, 04:58:27 EST by System User